Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Ekso Bionics Holdings, Inc. (EKSO) had Return on Investments of -18.99% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.06M |
|
$-2.71M |
|
$1.24M |
|
$0.82M |
|
$6.03M |
|
$-3.98M |
|
$1.27M |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
$-3.98M |
|
$-3.60M |
|
2.18M |
|
2.18M |
|
$-1.24 |
|
$-1.24 |
|
| Balance Sheet Financials | |
$15.97M |
|
$1.44M |
|
$7.19M |
|
$23.17M |
|
$6.71M |
|
$3.33M |
|
$5.52M |
|
$12.24M |
|
$10.93M |
|
$6.26M |
|
$10.93M |
|
2.60M |
|
| Cash Flow Statement Financials | |
$-5.41M |
|
$-0.05M |
|
$4.14M |
|
$6.49M |
|
$5.24M |
|
$-1.25M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
0.23 |
|
0.42 |
|
39.82% |
|
-193.24% |
|
-193.24% |
|
-- |
|
-131.70% |
|
-131.70% |
|
$-5.46M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.23 |
|
0.45 |
|
198.33 |
|
-24.79% |
|
-43.25% |
|
-11.69% |
|
|
Return on Investments |
-18.99% |
$4.20 |
|
$-2.50 |
|
$-2.48 |
|